MYRIAD GENETICS, INC. Deferred Income Tax Expense (Benefit)
MYRIAD GENETICS, INC. (MYGN) reported Deferred Income Tax Expense (Benefit) of $1.40 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-24
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2012-06-30 was $34.45M, a 1.57% increase year-over-year.
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2012-03-31 was -$2.92M.
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2011-12-31 was -$16.49M.
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2011-09-30 was -$14.79M.
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for fiscal 2025 was $1.40M.
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$2.30M.
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for fiscal 2023 was -$4.30M.
- MYRIAD GENETICS, INC. deferred income tax expense (benefit) for fiscal 2022 was -$30.50M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.40M 10-K · filed 2026-02-24 | |||||||
| 2024-12-31 | -$2.30M 10-K · filed 2026-02-24 | |||||||
| 2023-12-31 | -$4.30M 10-K · filed 2026-02-24 | |||||||
| 2022-12-31 | -$30.50M 10-K · filed 2025-02-28 | |||||||
| 2021-12-31 | -$31.70M 10-K · filed 2024-02-28 | |||||||
| 2020-12-31 | $35.20M 10-K · filed 2023-03-01 | |||||||
| 2020-06-30 | -$55.70M 10-K · filed 2023-03-01 | |||||||
| 2019-06-30 | $19.70M 10-K · filed 2022-02-25 | |||||||
| 2018-06-30 | -$22.90M 10-KT · filed 2021-03-16 | |||||||
| 2017-06-30 | $1.10M 10-K · filed 2019-08-13 | $1.70M 10-K · filed 2017-08-09 | ||||||
| 2016-06-30 | $13.00M 10-K · filed 2018-08-24 | $17.90M 10-K · filed 2016-08-10 | ||||||
| 2015-06-30 | -$3.70M 10-K · filed 2017-08-09 | |||||||
| 2014-06-30 | $700.00K 10-K · filed 2016-08-10 | $657.00K 10-K · filed 2014-08-13 | ||||||
| 2013-06-30 | -$200.00K 10-K · filed 2015-08-12 | -$217.00K 10-K · filed 2013-08-14 | ||||||
| 2012-06-30 | $34.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $31.52M derived: sum of 2 quarters · filed 2014-08-13 | $15.04M derived: sum of 3 quarters · filed 2014-08-13 | $250.00K 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-02 | -$19.41M derived: sum of 2 quarters · filed 2012-05-02 | -$34.20M 10-Q · filed 2012-05-02 | -$283.00K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-12-31 | -$16.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | -$31.27M 10-Q · filed 2012-02-01 | $2.64M derived: sum of 3 quarters · filed 2013-08-14 | -$11.07M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-09-30 | -$14.79M 10-Q · filed 2011-11-02 | $19.13M derived: sum of 2 quarters · filed 2013-08-14 | $5.42M derived: sum of 3 quarters · filed 2013-08-14 | -$7.92M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-06-30 | $33.92M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $20.21M derived: sum of 2 quarters · filed 2013-08-14 | $6.86M derived: sum of 3 quarters · filed 2013-08-14 | -$5.67M 10-K · filed 2013-08-14 | ||||
| 2011-03-31 | -$13.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-02 | -$27.05M derived: sum of 2 quarters · filed 2012-05-02 | -$39.59M 10-Q · filed 2012-05-02 | $39.59M 10-Q · filed 2011-05-04 | ||||
| 2010-12-31 | -$13.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | -$25.88M 10-Q · filed 2012-02-01 | $25.88M 10-Q · filed 2011-02-01 | |||||
| 2010-09-30 | -$12.54M 10-Q · filed 2011-11-02 | $12.54M 10-Q · filed 2010-11-03 | ||||||
| 2010-06-30 | -$28.05M 10-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |